Pancreatic cancer projects

PI/Investigator: Adile Orhan

Aim: The study is a randomized double-blinded placebo-controlled phase 2 study. We aim to determine the efficacy of preoperative treatment with propranolol in patients with pancreatic cancer on perioperative immune suppression and tumorinfiltrating lymphocytes in the primary tumor with a special emphasis on the intratumoral nerves

Status: The study is in collaboration with Rigshospitalet and is currently including patients